Search
Search Results
##search.searchResults.foundPlural##
-
MOLECULAR MECHANISMS OF INHIBITOR DEVELOPMENT IN HEMOPHILIA Guest Editor: Giancarlo Costaman
3384PDF: 1630HTML: 453 -
-
CYTOMEGALOVIRUS REACTIVATION IN ADULT RECIPIENTS OF AUTOLOGOUS STEM CELL TRANSPLANTATION: A SINGLE CENTER EXPERIENCE
1574PDF: 900HTML: 992figures: 198table 1: 198table2: 195table3: 198 -
ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children
2366PDF: 1192HTML: 687 -
CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA
8127PDF: 4311HTML: 7519 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1425HTML: 484PDF: 845 -
PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD
4598PDF: 1955HTML: 17860 -
PROCALCITONIN AS A BIOMARKER OF BACTERIAL INFECTION IN SICKLE CELL VASO-OCCLUSIVE CRISIS.
2106PDF: 1067HTML: 15662COVER LETTER: 200 -
TOLL-LIKE RECEPTORS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2631PDF: 889HTML: 17577Fig1 Caligaris: 190Fig.2 Caliga: 234 -
-
DONOR KIR3DL1/RECEPTOR HLA-BW4-80I COMBINATION REDUCES ACUTE LEUKEMIA RELAPSE AFTER UMBILICAL CORD BLOOD TRANSPLANTATION WITHOUT IN VITRO T-CELL DEPLETION KIR3DL1 with HLA-Bw4-80I reduces leukemia relapse
1424PDF: 564HTML: 212 -
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
2863PDF: 1034HTML: 5531 -
TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA
3426PDF: 1503HTML: 4017 -
POST-TRANSPLANT RELAPSE IN ACUTE LEUKEMIA: COMPARATIVE VALUE OF MRD AND CHIMERISM.
1099PDF: 535Suppl. Files: 132HTML: 251 -
THE ROLE OF WHITE BLOOD CELL COUNT IN PERIANAL PATHOLOGIES: A RETROSPECTIVE ANALYSIS OF HEMATOLOGIC MALIGNANCIES Role of white blood cell count in perianal pathologies
3872PDF: 1961HTML: 246 -
IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW
4891PDF: 2895HTML: 2320 -
-
GROUP-BASED TRAJECTORY MODELING OF PLATELET IN PATIENTS WITH APLASTIC ANEMIA: A STUDY BASED ON THE MIMIC DATABASE
1039PDF: 1035Suppl. Files: 651HTML: 153 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
4467PDF: 1538HTML: 1564Untitled: 243 -
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DIAGNOSTIC TOOLS, PROPHYLAXIS AND THERAPY
4217PDF: 1965HTML: 5346Table 1: 219 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3713PDF: 912HTML: 6728 -
CONTINUOUS CULTURES OF PLASMODIUM FALCIPARUM ESTABLISHED IN TANZANIA FROM PATIENTS WITH ACUTE MALARIA In vitro Malaria cultures
1778PDF: 565HTML: 215 -
AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR HIGH-RISK ACUTE LYMPHOBLASTIC LEUKEMIA: NON-RANDOMIZED STUDY WITH A MAXIMUM FOLLOW-UP OF MORE THAN 22 YEARS
1575PDF: 926HTML: 1969Figure: 183Tables: 195ALL revision 1: 268response to reviewer: 189 -
COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.
2572PDF: 959HTML: 319 -
THE HISTORY OF DEFERIPRONE (L1) AND THE COMPLETE TREATMENT OF IRON OVERLOAD IN THALASSAEMIA The history and roles of deferiprone
2467PDF: 1613HTML: 662 -
SOCIOECONOMIC STATUS IS GLOBALLY A PROGNOSTIC FACTOR FOR OVERALL SURVIVAL OF MULTIPLE MYELOMA PATIENTS; SYNTHESIS OF STUDIES AND REVIEW OF THE LITERATURE SES as prognostic factor for myeloma survival
2085PDF: 855HTML: 262 -
-
MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)
4062PDF: 1561HTML: 9194Untitled: 286Untitled: 193Untitled: 177Untitled: 171Untitled: 195Untitled: 350 -
THE PROTHROMBOTIC STATE ASSOCIATED WITH SARS-COV-2 INFECTION: PATHOPHYSIOLOGICAL ASPECTS COVID and Thrombosis
2035PDF: 827HTML: 229 -
COAGULOPATHY IN BETA-THALASSEMIA: CURRENT UNDERSTANDING AND FUTURE PERSPECTIVES
1197PDF: 492HTML: 8189







